Sheikh Arslan Sehgal

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Venues

PloS one

BioMed research international

Journal of cellular physiology

University of Chinese Acadmey of Sciences

Univeristy of Chinese Academy of Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Chinese Acadmey of Sciences Sep 7o 2015 - May 29o 2019

China

PhD (TWAS-Research-Scholar) :: Institute of Zoology

Education History

Univeristy of Chinese Academy of Sciences - May 29o 2019

China

PHD :: Institute of Zoology

Publications

Abbeha Malik, Muhammad Nasir Iqbal, Sidrah Ashraf, Muhammad Saleem Khan, Samar Shahzadi, Muhammad Farhan Shafique, Zureesha Sajid, Muhammad Sajid, Sheikh Arslan Sehgal
In silico elucidation of potential drug targets against oxygenase domain of Human eNOS Dysfunction. PloS one 18 (4) (2023)
Abbeha Malik, Muhammad Nasir Iqbal, Sidrah Ashraf, Muhammad Saleem Khan, Samar Shahzadi, Muhammad Farhan Shafique, Zureesha Sajid, Muhammad Sajid, Sheikh Arslan Sehgal
In silico elucidation of potential drug targets against oxygenase domain of Human eNOS Dysfunction. PloS one 18 (4) (2023)
Abbeha Malik, Muhammad Nasir Iqbal, Sidrah Ashraf, Muhammad Saleem Khan, Samar Shahzadi, Muhammad Farhan Shafique, Zureesha Sajid, Muhammad Sajid, Sheikh Arslan Sehgal
In silico elucidation of potential drug targets against oxygenase domain of Human eNOS Dysfunction. PloS one 18 (4) (2023)
Abbeha Malik, Muhammad Nasir Iqbal, Sidrah Ashraf, Muhammad Saleem Khan, Samar Shahzadi, Muhammad Farhan Shafique, Zureesha Sajid, Muhammad Sajid, Sheikh Arslan Sehgal
In silico elucidation of potential drug targets against oxygenase domain of Human eNOS Dysfunction. PloS one 18 (4) (2023)
Ali Umar, Muhammad Saleem Khan, Sheikh Arslan Sehgal, Kamran Jafar, Shabbir Ahmad, Ahmad Waheed, Muhammad Waseem Aslam, Muhammad Wajid, Tanzil Ur Rehman, Tehmina Khan, Allah Ditta, Hasnain Akmal, Muhammad Ashfaq, Tariq Javed, Rida Tahir
Epidemiological studies of sleep disorder in educational community of Pakistani population, its major risk factors and associated diseases. PloS one 17 (4) (2022)
Muhammad Sajid, Saigha Marriam, Hamid Mukhtar, Summar Sohail, Muhammad Sajid, Sheikh Arslan Sehgal
Epitope-based peptide vaccine design and elucidation of novel compounds against 3C like protein of SARS-CoV-2. PloS one 17 (3) (2022)
Muhammad Waqas, Ali Haider, Abdur Rehman, Muhammad Qasim, Ahitsham Umar, Muhammad Sufyan, Hafiza Nisha Akram, Asif Mir, Roha Razzaq, Danish Rasool, Rana Adnan Tahir, Sheikh Arslan Sehgal
Immunoinformatics and Molecular Docking Studies Predicted Potential Multiepitope-Based Peptide Vaccine and Novel Compounds against Novel SARS-CoV-2 through Virtual Screening. BioMed research international 2021 (2021)
Rana Adnan Tahir, Afsheen Bashir, Muhammad Noaman Yousaf, Azka Ahmed, Yasmine Dali, Sanaullah Khan, Sheikh Arslan Sehgal
In Silico identification of angiotensin-converting enzyme inhibitory peptides from MRJP1. PloS one 15 (2) (2020)
Rana Adnan Tahir, Hao Wu, Naima Javed, Anila Khalique, Seemab Amjad Fateh Khan, Asif Mir, Muhammad Saad Ahmed, George E Barreto, Hong Qing, Ghulam Md Ashraf, Sheikh Arslan Sehgal
Pharmacoinformatics and molecular docking reveal potential drug candidates against Schizophrenia to target TAAR6. Journal of cellular physiology 234 (8) (2018)
Sheikh Arslan Sehgal
Pharmacoinformatics, Adaptive Evolution, and Elucidation of Six Novel Compounds for Schizophrenia Treatment by Targeting DAOA (G72) Isoforms. BioMed research international 2017 (2017)

Sheikh Arslan Sehgal.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sheikh Arslan Sehgal